Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wanted data good enough to ...

The industry of biotech is a great place to look for such stocks since so many of these companies are developing cutting-edge ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the third quarter: MoonLake ...

There are many promising corporations that investors can buy on a dip due to recent market volatility or company-specific ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Discover why IBB's focused approach makes it preferable to XBI. Learn about their objectives, diversification, and ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Oncolytics Biotech Inc shares N.ONCY are trading up $0.09 at $1.01.

Investing.com -- PDS Biotechnology Corp (NASDAQ: PDSB) stock rose 3.8% after the company announced that its clinical trial for metastatic colorectal cancer treatment has met pre-set criteria for ...